Literature DB >> 14567727

Five-year follow-up of routine outpatient test turnaround time: a College of American Pathologists Q-Probes study.

Paul Valenstein1, Molly Walsh.   

Abstract

CONTEXT: Timely reporting of outpatient tests can increase efficiency of care and improve customer satisfaction.
OBJECTIVES: We conducted a survey in 2002 to determine how quickly hospital-based laboratories turned around routine requests for 3 common assays and compared the results with a similar survey conducted in 1997.
DESIGN: One hundred eighteen laboratories prospectively recorded the collection-to-verification turnaround time for 9252 complete blood cell counts (CBCs), 8832 thyroid tests, and 9193 basic metabolic panels.
RESULTS: The median facility reported all test results by 7:00 am of the weekday immediately after the date of specimen collection. The bottom 10% of institutions reported 99% of CBCs and basic metabolic panels within 1 day and 60% of thyroid tests within 1 day. The 65 institutions that participated in both the 1997 and 2002 surveys showed significant overall improvement in turnaround time for all 3 types of tests (P <.001). In 2002, federal institutions had significantly slower turnaround times than nonfederal institutions for CBC tests (P <.001), thyroid tests (P =.03), and basic metabolic panels (P <.001). Other demographic and practice variables were not associated with turnaround time.
CONCLUSION: The turnaround time of routine outpatient tests appears to have improved between 1997 and 2002.

Entities:  

Mesh:

Year:  2003        PMID: 14567727     DOI: 10.5858/2003-127-1421-FFOROT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Laboratory turnaround time.

Authors:  Robert C Hawkins
Journal:  Clin Biochem Rev       Date:  2007-11

Review 2.  Turnaround Time (TAT): Difference in Concept for Laboratory and Clinician.

Authors:  Hara P Pati; Gurmeet Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-08       Impact factor: 0.900

Review 3.  Mapping turnaround times (TAT) to a generic timeline: a systematic review of TAT definitions in clinical domains.

Authors:  Bernhard Breil; Fleur Fritz; Volker Thiemann; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2011-05-24       Impact factor: 2.796

4.  Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.

Authors:  Anna K Füzéry; Joshua Levin; Maria M Chan; Daniel W Chan
Journal:  Clin Proteomics       Date:  2013-10-02       Impact factor: 3.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.